U.S.-listed shares rose over 4% in Wednesday's premarket after it announced a significant restructuring plan, including a ...

He also articulated a very specific doctrine about the role of an FDA commissioner, one that is limited in its power and ...

Galapagos plans to split into two entities by mid-2025, focusing its core business on cell therapies while spinning off a new ...